Vivos Therapeutics Inc
VVOS
$0.18+1.32%
End of day · as of Sep 13, 2026, 4:18 PM ET
Mkt cap
$7.10M
EV/Sales
0.46
P/E ratio
N/A
FY2025 Revenue
$17.44M
EPS (TTM)
$-2.33
Gross Margin (FY2025)
60.44%
Profit Margin (FY2025)
-121.37%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
Latest reported VVOS revenue for 2025-12-31 was $17.4M. Net income was -$21.2M. Revenue was up 16.0% from 2024-12-31 to 2025-12-31. VVOS currently screens at market cap $7.1M.
Use this VVOS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full VVOS income, balance, and cash tables.
Vivos Therapeutics Inc (VVOS) is a medical devices company in the Healthcare sector.
Latest cached Vivos Therapeutics Inc (VVOS) revenue for Dec 31, 2025 was $17.4M. Net income was -$21.2M. Statements: https://lician.com/financials/vvos
Vivos Therapeutics Inc (VVOS) market capitalization is $7.1M on the latest cached snapshot.
Vivos Therapeutics Inc (VVOS) cached previous close $0.18; day range $0.18 – $0.19; volume 1,437,480. Session quote: https://lician.com/quote/vvos
Vivos Therapeutics Inc (VVOS) latest cached earnings event is "VVOS earnings" on Aug 18, 2026. Earnings calendar: https://lician.com/earnings
The latest cached VVOS filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/vvos